Notably, downregulated PHLPP2 by microRNA-93 (miR-93) has been reported to activate phosphoinositide 3-kinase (PI3K)/Akt signaling, which ultimately favors glioma cell promotion [18]. Here, PHLPP2 is linked to central nervous system cancer.